Okay/ CNE100005XL3 /
2024-06-21 9:00:00 AM | Chg. -0.30 | Volume | Bid2024-06-21 | Ask9:00:03 AM | High | Low |
---|---|---|---|---|---|---|
21.75CNY | -1.36% | 1.67 mill. Turnover: 36.52 mill. |
21.75Bid Size: 2,116 | 21.77Ask Size: 232 | 22.54 | 21.41 |
GlobeNewswire
06-18
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD ...
GlobeNewswire
05-29
Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024
GlobeNewswire
05-21
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire
04-02
Noble Transfer Launches Deluxe Limousine Service in Paris, Pioneering Luxury Travel Solutions
GlobeNewswire
04-02
Parks! America Needs Experienced Operators; Lisa Brady, the Current CEO, Isn’t One, states Focused C...
GlobeNewswire
01-10
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
GlobeNewswire
2023-12-20
The Chicago School President Michele Nealon Addresses Holiday Blues and Offers Tips for Improving Me...
GlobeNewswire
2023-10-24
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More